IKONISYS SA (ALIKO.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALIKO - FR00140048X2 - Common Stock
ALIKO.PA Key Statistics, Chart & Performance
The current stock price of ALIKO.PA is 1.61 EUR. In the past month the price decreased by -0.62%. In the past year, price increased by 8.78%.
ALIKO.PA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ALIKO.PA. When comparing the yearly performance of all stocks, ALIKO.PA turns out to be only a medium performer in the overall market: it outperformed 69.25% of all stocks.
ALIKO.PA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALIKO.PA Forecast & Estimates
9 analysts have analysed ALIKO.PA and the average price target is 2.86 EUR. This implies a price increase of 77.39% is expected in the next year compared to the current price of 1.61.
ALIKO.PA Ownership
About ALIKO.PA
Company Profile
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
Company Info
IKONISYS SA
62 Rue De Caumartin, Paris 9
Paris ILE-DE-FRANCE FR
Employees: 10
IKONISYS SA / ALIKO.PA FAQ
What does IKONISYS SA do?
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
Can you provide the latest stock price for IKONISYS SA?
The current stock price of ALIKO.PA is 1.61 EUR. The price increased by 0.63% in the last trading session.
Does ALIKO stock pay dividends?
ALIKO.PA does not pay a dividend.
What is the ChartMill technical and fundamental rating of ALIKO stock?
ALIKO.PA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Where is IKONISYS SA (ALIKO.PA) stock traded?
ALIKO.PA stock is listed on the Euronext Paris exchange.
Can you provide the number of employees for IKONISYS SA?
IKONISYS SA (ALIKO.PA) currently has 10 employees.